Ondo (ONDO) is currently trading at $0.5028, a 5.67% increase over the last 24 hours. Despite the positive price movement, trading activity cooled considerably, with volume slipping 35.06% to $96.64 million. Over the past week, ONDO has maintained the same price level, reflecting a 2.22% decline but demonstrating notable resilience under pressure. According to recent […]Ondo (ONDO) is currently trading at $0.5028, a 5.67% increase over the last 24 hours. Despite the positive price movement, trading activity cooled considerably, with volume slipping 35.06% to $96.64 million. Over the past week, ONDO has maintained the same price level, reflecting a 2.22% decline but demonstrating notable resilience under pressure. According to recent […]

Ondo (ONDO) Surges: Can It Hit $2.00 After SEC Clearance?

3 min read
  • ONDO price rebounds, trading at $0.5028 despite weekly declines.
  • Analyst outlook turns bullish, projecting targets up to $2.00 as accumulation strengthens.
  • SEC closes investigation, clearing Ondo Finance and paving the way for U.S. expansion in tokenized securities.

Ondo (ONDO) is currently trading at $0.5028, a 5.67% increase over the last 24 hours. Despite the positive price movement, trading activity cooled considerably, with volume slipping 35.06% to $96.64 million. Over the past week, ONDO has maintained the same price level, reflecting a 2.22% decline but demonstrating notable resilience under pressure.

Source: CoinMarketCap

According to recent technical observations, buyers have re-emerged at a critical support zone, helping the token stabilize after a period of corrective movement. Market participants note that ONDO’s ability to defend this region indicates continued confidence in its long-term fundamentals.

ONDO Near Key Support in Descending Channel

Crypto analyst Bit Amberly reports that ONDO is currently positioned near the lower boundary of a descending channel on the three-day chart. Despite recent sell-offs, the underlying support remains intact, with accumulation patterns gradually strengthening.

Amberly suggests that the current consolidation phase may serve as a launchpad for an upward trend, should momentum continue to build. Projected bullish targets include $0.56, $0.86, $1.14, $1.50, and ultimately $2.00, contingent on sustained buying pressure and a successful breakout from the channel.,

Traders tracking mid-term movements view this setup as a potential early stage of reversal, though broader market sentiment and regulatory factors continue to play influential roles.

Source: X

Also Read | Ondo Finance SEC Probe Ends, No Charges, Boosting Tokenized Assets

SEC Concludes Ondo Finance Probe With No Charges

In a parallel development shaping investor sentiment, the U.S. Securities and Exchange Commission (SEC) has officially closed its multi-year investigation into Ondo Finance, issuing no enforcement actions. The inquiry examined the legal status of ONDO and the company’s practices involving tokenized real-world assets, including U.S. Treasuries and equities.

Founder and CEO Nathan Allman confirmed the conclusion, noting that Ondo had received formal notification that the investigation resulted in no recommended charges. This regulatory clarity is expected to significantly ease Ondo’s operational environment, particularly within the U.S. market.

Industry analysts interpret the decision as a positive signal for the broader tokenization sector. With legal uncertainties reduced, Ondo Finance may now accelerate its expansion of tokenized securities offerings, potentially contributing to the growing integration of blockchain-based financial instruments in traditional markets.

As regulatory acceptance strengthens, experts expect increased liquidity, rising institutional participation, and broader adoption of tokenized assets, positioning Ondo as a key beneficiary in the evolving financial landscape.

Also Read | ONDO stabilizes at support and signals a potential rally toward $1.18

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

Trump swears he'll donate winnings in $10 billion lawsuit against his own IRS

President Donald Trump told NBC News' Tom Llamas in an interview released on Wednesday that he has no interest in actually keeping any money he wins from his lawsuit
Share
Rawstory2026/02/05 10:43
US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike

The post US President Donald Trump says Warsh would’ve lost Fed if he pledged rate hike appeared on BitcoinEthereumNews.com. US President Donald Trump said that
Share
BitcoinEthereumNews2026/02/05 10:23
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11